Rise Technology
A subsidiary of a European pharmaceutical company has launched in the US to trial a new drug against pattern hair loss. Also, preclinical data from the stock market-traded company Omega Therapeutics is shown. Dermaliq DLQ01 Drug Candidate On January 18, 2022, Novaliq GmbH and strategic investment partners announced the formation of a Dermaliq Therapeutics Inc.,…
Read More
In this article we will take a look at two new companies developing therapies for hair growth in 2021. HaplnScience: Targeting The Cause Of Aging In Hair Follicles HaplnScience is a new company developing therapies for age-related diseases including androgenic alopecia, based where else, but South Korea. The company was founded in 2018 by experienced…
Read More